S 4109·Federal·senate
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Floor Vote ScheduledFiled Mar 17, 2026
Sponsor: Sen. Reed, Jack [D-RI] (D)
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Jun 22, 2026
Summary
The bill renews the federal program that supports stem‑cell therapies, keeping the C.W. Bill Young Cell Transplantation Program funded at $31,009,000 now and $33,009,000 each year from 2027 to 2031. It also pushes back the deadline for the cord‑blood inventory requirement from 2026 to 2031. The measure is intended to preserve research and treatment options for patients who rely on stem‑cell transplants.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 4109 changes status, plus AI-powered summaries and stage predictions.
Sign up free